Press monitoring
First Clinical Trial of Gene Therapy for Muscular Dystrophy Now Under Way
7.4.2006 | Press monitoring
The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina at Chapel Hill's School of Medicine and the University of Pittsburgh. In the trial, six boys with DMD will receive replacement genes for an essential muscle...
Cloned horses latest move for controversial field
7.4.2006 | Press monitoring
The company that cloned the first horse to be sold commercially said on Thursday it plans to market 22 similar animals before 2008, marking another step forward for the controversial technology.
Eating transgenic tobacco prevents cervical cancer
7.4.2006 | Press monitoring
Human Papillomaviruses (HPV) are the causative agents for cervical, skin, head and neck tumors. In developing countries, cervical cancer is one of the main causes of cancer-related deaths. However, Italian researchers have now developed an immunologically active, cost-efficient vaccine against HPV.
Drugs from llamas? Belgian firm eyes IPO next year
7.4.2006 | Press monitoring
A Belgian biotechnology company using llama DNA to develop a new class of drugs hopes to float on the Euronext stock market next year, its incoming chief executive said on Monday.
US, African scientists seek biotech answer to hunger
7.4.2006 | Press monitoring
As he pores over plant tissue and petri dishes in a biotech seed lab in Johnston, Iowa, Luke Mehlo is half a world away from his home in South Africa.
US scientists make pigs with heart-healthy fats
7.4.2006 | Press monitoring
U.S. scientists said on Sunday they had genetically engineered pigs that make beneficial fatty acids and may one day serve as a healthier source of pork chops or bacon.
OHSU Study Aims To Halt Alzheimer's By Blocking Enzyme
7.4.2006 | Press monitoring
Inhibiting gamma secretase may prevent amyloid plaque build-up thought to trigger disease, but trials continue
Small science
7.4.2006 | Press monitoring
Technology: The nanotech future is just beginning | Lynde Langdon
Glaxo starts human tests of bird flu vaccines
6.4.2006 | Press monitoring
WASHINGTON -- GlaxoSmithKline said yesterday it has started human trials of two new bird flu vaccines and that if the treatments work, they could be ready to manufacture by the end of the year.
Powerful new tool for studying brain development
6.4.2006 | Press monitoring
The mouse Brain Gene Expression Map at St. Jude shows where and when genes influence development of the brain and helps researchers study links between gene mutations and cancers
